Clinical Trials Introduction
1 Multiplicity Adjustment For Clinical Trials with Two Doses of an Active Treatment and Multiple Primary and Secondary Endpoints Hui Quan 1, Tom Capizzi.
David Walk
Using Genomics in the Design of Phase III Clinical Trials
Promises and Perils of Translational Research at Academic Health Centers: The CCHMC Model Timothy P. Cripe, MD, PhD Faculty Cross-Talk October 5, 2006.
Hui Quan 1 , Tom Capizzi 1 , Ji Zhang 2 1 Merck Research Laboratories 2 Sanofi-Synthelabo Research
Transparency and access to medical research Dr. Wim Weber European editor, BMJ.
The Center for Palliative Care Education Palliative Management of Dyspnea in HIV/AIDS.
Goldstraw et al. J Thorac Oncol 2007
